TETRACENE, 98.0%, 5g

2-Amino-1-p-tolyl-ethanone; hydrochloride, 95.0%, 5g

Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, monopotassiumsalt, 98%, 25g

2,6-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine, 98.0%, 5g

7-Chloro-1H-indazol-6-amine, 95.0%, 10g

Glycyl-L-tyrosine Hydrate>98.0%(T)5g

Guanidinium dihydrogen phosphate, 98%, 25g

2-Chloro-3-methoxybenzonitrile, 97%, 5g

(R)-4-(TERT-BUTOXYCARBONYL)-6,6-DIMETHYLMORPHOLINE-2-CARBOXYLIC ACID, 95.0%, 1g

2-(tert-Butoxycarbonyl)-2-azabicyclo[2.1.1]hexane-5-carboxylic acid, 95%, 500mg

4,4'-Dimethoxydiphenylamine>98.0%(GC)(T)1g

4-AMINO-2,2-DIFLUOROBUTANOIC ACID HCL, 95%, 250mg

GC capillary column ROTI®Cap-5, 25 m, 0.25 mm, 0.10 µm, 1 Piece(s)